Ataraxis AI: $20.4 Million (Series A) Raised For Transforming Precision Medicine In Cancer Care

Ataraxis AI Raises $20.4 Million in Series A Led by AIX Ventures

Ataraxis AI to Transform Precision Medicine in Cancer Care with $20.4 Million Series A

#NYCtech Week in Review: 1/5/25 – 1/11/25

Oncology Specialist

Ataraxis AI is an AI precision medicine company focused on revolutionizing cancer treatment through advanced technology. They are seeking an Oncology Specialist to drive sales growth and market penetration of their oncology products by establishing relationships with oncologists in a designated territory.

Sign up with Google

Sign in with Google